Tampa, FL, Jan. 24, 2022 (GLOBE NEWSWIRE) -- RemSleep Holdings Inc (OTC PINK: RMSL), a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive sleep apnea patients, is proud to announce that we have partnered with Preya Co and MCAP Mediawire to maximize our communication and exposure with current and potential shareholders in conjunction with refining and broadening our overall messaging and outreach. This is in anticipation and because of the overwhelming response from the public and medical field from our pending DeltaWave 510k approval and market release.
“We feel we owe it to our current and future investors to have partnered with a gold star firm to assist us with our investor relations moving forward. Maintaining an open line of communication with our shareholders and providing consistent, timely updates will only serve to add value to our company,” said Tom Wood, CEO of RemSleep.
Ms.Preya Narain, founder of Preya Co is an experienced microcap consultant based in New York. Her background as a highly active day-trader led her seeking to serve companies and investors with greater purpose, impact, positivity and perspective. In 2020, she assembled a team of high-performing professionals and formed Preya Co., a consulting team with over twenty years combined experience in OTC, OTCQB/QX, foreign and NASDAQ markets. Preya Co. currently serves as a Corporate Advisor, Investor Relations Manager, and Social Media Manager for several publicly traded companies in the space, as well as forensic research and extensive due diligence reports for issuers, shareholders, regulatory agencies and federal organizations.
MCAP Mediawire is a top contender in the news distribution arena, offering the number one press release, digital media and financial disclosure service for microcap and exchange listed companies. Their services give companies exposure to an audience of millions, including journalists, investors, day-traders, fund managers and social media/messaging platforms. This enables press releases, earnings statements, branded articles, shareholder updates, corporate achievements to reach a vast and diverse audience around the world.
We encourage our shareholders to visit our official Twitter account for RemSleep Holdings Inc at https://twitter.com/RemsleepInc.
About RemSleep Holdings Inc.
RemSleep Holdings, Inc. is a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive Sleep Apnea patients. Our focus is primarily designing and manufacturing devices and products for the treatment of Sleep Apnea and other respiratory conditions. With over 30 years of collective experience in CPAP therapy, the REMSleep team has extensive knowledge and understanding of CPAP and the challenges of patient compliance. We diligently strive for our products to make the difference and improve the condition of those suffering from Sleep Apnea.
Forward-Looking Statements
Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words "may", "will", "should", "continue", "expect", "anticipate", "estimate", "believe", "intend", "plan" or "project" or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company's ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company to obtain sufficient financing to execute the Company's business plan; competition; regulation and anticipated and unanticipated costs and delays, and other risks disclosed in the Company's public disclosure record on file with the relevant securities regulatory authorities. No information in this press release should be construed as any indication whatsoever of the Company's future revenues, results of operations or stock price. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.
Investor Relations Contact
Preya Narain
347-837-0626
info@preya.co
